If you need more lookups,
subscriptions start at $34 USD/month.
Derek Leishman Location
Carmel, IN, US
Derek Leishman Work
Vice President, Translational and Quantitative Toxicology @ Eli Lilly and Company (October 2022 - Present)
Senior Research Fellow, Translational and Quantitative Toxicology @ Eli Lilly and Company (July 2018 - October 2022)
Senior Research Fellow, Global PK and PD and Pharmacometrics @ Eli Lilly and Company (March 2013 - July 2018)
Senior Research Fellow @ Eli Lilly and Company (October 2012 - March 2013)
Research Fellow and Head of Global Safety Pharmacology @ Eli Lilly and Company (June 2005 - September 2012)
Research Fellow @ Eli Lilly and Company (June 2005 - January 2008)
Adjunct Associate Professor of Pharmacology and Toxicology @ (October 2018 - Present)
Diplomate in Safety Pharmacology @ Safety Pharmacology Society (January 2013 - Present)
Member @ Safety Pharmacology Society (January 2003 - Present)
President @ Safety Pharmacology Society (January 2013 - December 2013)
Adjunct Professor @ (August 2012 - Present)
Scientist to Research Fellow @ (October 1993 - June 2005)
Research Fellow @ (January 1993 - January 2005)
scientist @ (January 1993 - January 2005)
research fellow @ (January 1993 - January 2005)
Research Fellow @ (January 1993 - January 2005)
Elecrtophysiologist @ Marion Merrell Dow (May 1992 - October 1993)
Higher Scientific Officer @ Rowett Research Institute (October 1991 - May 1992)
Derek Leishman Education
University of Aberdeen
BSc(Hons); PhD (Pharmacology)
1982-1990
Derek Leishman Skills
Drug Discovery
Pharmacology
In Vivo
Toxicology
In Vitro
Clinical Development
Drug Development
GLP
Lifesciences
Biomarkers
Pharmaceutical Industry
Neuroscience
Translational Medicine
Animal Models
Ion Channels
Physiology
PK/PD
Pharmacokinetics
Drug Metabolism
CRO
Biochemistry
Regulatory Submissions
IND
Biomarker Discovery
Clinical Trials
Pharmacodynamics
Safety Pharmacology
Life Sciences
Clinical Research
Biotechnology
CRO Management
Pharmacometrics
Data Analysis
Higher Education
Molecular Biology
Marketing
Customer Service
Diabetes
Research
Science
Leadership
Derek Leishman Summary
Derek Leishman, based in Carmel, IN, US, is currently a Vice President, Translational and Quantitative Toxicology at Eli Lilly and Company. Derek Leishman brings experience from previous roles at Eli Lilly and Company. Derek Leishman holds a 1982 - 1990 BSc(Hons); PhD in Pharmacology @ University of Aberdeen. With a robust skill set that includes Drug Discovery, Pharmacology, In Vivo, Toxicology, In Vitro and more. Derek Leishman has 2 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Derek Leishman?
Find contact details for 700 million professionals.